|
26.3.2018 |
EN |
Official Journal of the European Union |
C 112/42 |
Action brought on 5 February 2018 — Endoceutics v EUIPO — Merck (FEMIVIA)
(Case T-59/18)
(2018/C 112/53)
Language in which the application was lodged: English
Parties
Applicant: Endoceutics, Inc. (Quebec, Quebec, Canada) (represented by: M. Wahlin, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Merck KGaA (Darmstadt, Germany)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant
Trade mark at issue: EU word mark ‘FEMIVIA’ — Application for registration No 13 148 986
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 27 November 2017 in Case R 280/2017-2
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order EUIPO to pay the Applicant’s costs both at EUIPO and at the General Court. |
Plea in law
|
— |
Infringement of Article 8(1)(b) of Regulation No 2017/1001. |